TPAD for Recovery of Standing After Severe SCI
Kessler Foundation · NCT06643312
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- October 22, 2024
- Record last updated
- December 16, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to investigate how standing and sitting balance control is altered after spinal cord injury (SCI) and how a new type of robotic assistive device may be used to improve muscle function. This device is called the Tethered Pelvic Assist Device, or TPAD.
The main aims are to
- Examine muscle activation patterns generated during different types of standing in spinal cord injured individuals using robotic assistance or self-assistance for balance
2 and 3. Examine the effectiveness of robotic-assisted stand training in the improvement of posture control during different types of standing and sitting in spinal cord injured individuals.
Participants will be placed into one of 5 groups based on a physical classification of their spinal cord injury:
Group 1:
- Individuals with SCI that can stand independently
- Will receive TPAD training
- Will undergo standing, posture, sitting, and stepping assessments
- Participation in this group will last about six months
Group 2:
- Individuals with SCI that cannot stand independently
- Will receive TPAD training
- Will undergo standing, posture, sitting, and stepping assessments
- Participation in this group will last about 6 months
Group 3:
- Individuals with SCI that can stand independently
- Will undergo standing and posture assessments
- Participation in this group will last about 2 weeks
Group 4:
- Individuals with SCI that cannot stand independently
- Will undergo standing and posture assessments
- Participation in this group will last about 2 weeks
Group 5:
- Individuals without a SCI
- Will undergo standing, posture, and sitting assessments
- Participation in this group will last about 2 weeks
Being studied: The Tethered Pelvic Assist Device (TPAD)
Conditions: SCI - Spinal Cord Injury
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- At least 18 years of age at the time of enrollment;
- stable medical condition
- at least one year post-spinal cord injury (Groups 1-4)
- non-progressive, traumatic SCI above T10 (Groups 1-4)
- Injury Grade A, B, C or D (Groups 1-4)
- ability to stand independently for short periods of time, not exceeding 1 hour (Groups 1 and 3)
- inability to stand independently (Groups 2 and 4)
Exclusion Criteria
- unwillingness to wean from anti-spasticity medications;
- untreated painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore or urinary tract infection
- history of bone disease unassociated with decreased bone mineral density due to spinal cord injury
- ongoing drug abuse
- untreated psychiatric disorders or clinical depression
- received botox injections in lower extremities in the prior six months
- Cardiopulmonary disease that may interfere with assessments
- Untreated severe and persistent dysautonomia
- Neurological injury or disease (Group 5)
- Orthopedic injury or condition (Group 5)
Recruiting US locations
Kessler Foundation
West Orange, NJ 07052
Site contact: Research Manager · 973-324-3557 · LMartinez@KesslerFoundation.Org
Study contacts (from the official record)
- Research Manager · 9733243557 · LMartinez@KesslerFoundation.Org
- Gail F Forrest, PhD · 9733243518
Similar studies in New Jersey
All healthy volunteers studies in New Jersey →- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Fair Lawn, NJ + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Marlton, NJ + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Jersey City, NJ + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants
Harmony Biosciences Management, Inc.
- Location
- Eatontown, NJ
- Eligibility basics
- Ages 18–55